Sorrento Therapeutics, Inc.
SRNEDelisted Apr 12, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000850261
Sorrento Therapeutics, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 20, 2023; 224 institutions reported holding it in 13F filings for Q4 2022, worth $180.7M in total; Oaktree Capital was the only superinvestor holding it.
Superinvestors holding SRNE, Q4 2022
1 superinvestor reports holding Sorrento Therapeutics, Inc. on Form 13F, worth $118.7K in total. Weight is Sorrento Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q3 2022.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Oaktree CapitalHoward Marks | <0.1% | 134,000 | $118.7K | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SRNE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2022
1 superinvestor holding at quarter end
- Reduced
- Oaktree Capital (−10.7%)
Q4 2021
1 superinvestor holding at quarter end
- Added
- Oaktree Capital (+11.9%)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- Oaktree Capital (−58.1%)